These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9221596)
61. [Trial of the protective activity of ribosomal Sonne vaccine in monkeys]. Levenson VI; Dzhikidze EK; Stasilevich ZK; Kavtaradze KN; Subbotina IuL Vestn Akad Med Nauk SSSR; 1986; (3):69-72. PubMed ID: 3518271 [No Abstract] [Full Text] [Related]
62. [Use of the indirect hemagglutination test in the examination of persons having contact with Sonne dysentery patients]. Zueva LP Vopr Okhr Materin Det; 1970 Mar; 15(3):91. PubMed ID: 4910770 [No Abstract] [Full Text] [Related]
63. [Clinico-morphologic features of dysentery caused by Sonne shigellae]. Livshits LA Vrach Delo; 1972 Sep; 9():139-42. PubMed ID: 4572162 [No Abstract] [Full Text] [Related]
64. [On cases of Sonnei dysentery with course of the food poisoning type]. Avakov AS; Gaĭdamakin AV Voen Med Zh; 1969 Apr; 4():67-8. PubMed ID: 4897925 [No Abstract] [Full Text] [Related]
65. Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis. Cohen D; Slepon R; Green MS Int J Epidemiol; 1991 Jun; 20(2):546-50. PubMed ID: 1917263 [TBL] [Abstract][Full Text] [Related]
66. [Reactivity and immunogenicity of the Sonne dysentery detergent monovaccine]. Kambarova OI; Sel'kina LE; Shpiliuk GF; Bodazhkova KN; Dudkina MI Zh Mikrobiol Epidemiol Immunobiol; 1975 Dec; (12):34-8. PubMed ID: 766518 [TBL] [Abstract][Full Text] [Related]
67. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R; Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770 [TBL] [Abstract][Full Text] [Related]
68. [The clinico-pathogenetic significance of disorders of the immune status in dysentery]. Iushchuk ND; Frolov VM; Peresadin NA; Kalender SD Ter Arkh; 1990; 62(11):36-9. PubMed ID: 2094988 [TBL] [Abstract][Full Text] [Related]
69. [The comparison of tests for Shigella sonnei in feces, using an indirect immunofluorescent technic and bacterial cultivation]. Janousková I; Wiedermannová D Cesk Pediatr; 1966 Aug; 21(8):725-8. PubMed ID: 5341153 [No Abstract] [Full Text] [Related]
70. [Dysentery in Poland in 2001]. Stypułkowska-Misiurewicz H; Gonera E Przegl Epidemiol; 2003; 57(1):77-84. PubMed ID: 12926313 [TBL] [Abstract][Full Text] [Related]
71. [The importance of immunofluorescence and cytologic indices in the diagnosis and prognosis of the course of dysentery]. Shuvalova EP; Polotskiĭ VIu Ter Arkh; 1989; 61(11):69-72. PubMed ID: 2699099 [No Abstract] [Full Text] [Related]
72. [Use of fluorescence labelled anti-Shigella sonnei sera in general practice. I. Comparative studies between fluorescence microscopic and bacteriologic diagnosis]. Markuse I; Thilo W; Deutsch J Z Gesamte Hyg; 1969 Jul; 15(7):537-9. PubMed ID: 4906390 [No Abstract] [Full Text] [Related]
73. [Duration of bacterial discharge in Sonne dysentery]. Sharipov RZ; Laue F Zh Mikrobiol Epidemiol Immunobiol; 1977 Dec; (12):39-43. PubMed ID: 341613 [TBL] [Abstract][Full Text] [Related]
74. [Clinical parallels in acute Flexner, Newcastle and Sonne dysenteries]. Zhamerichev SS Voen Med Zh; 1972 May; 5():46-9. PubMed ID: 4576191 [No Abstract] [Full Text] [Related]
75. [Immunoelectrophoretic analysis of the antigenic structure of Sh. sonnei]. Nguen Zuĭ Kho ; Belaia IuA Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):55-61. PubMed ID: 79280 [TBL] [Abstract][Full Text] [Related]
76. Culture of the faeces in the diagnosis of Sonne dysentery: a statistical method for estimating the true isolation rate. Tillett HE; Thomas ME Int J Epidemiol; 1974 Jun; 3(2):177-81. PubMed ID: 4604284 [No Abstract] [Full Text] [Related]
77. [Determination of the physicochemical nature of specific antibodies in the different forms and course of dysentery in children]. Nesterina LF; Vasil'eva IG Vopr Okhr Materin Det; 1973 Dec; 18(12):16-20. PubMed ID: 4594382 [No Abstract] [Full Text] [Related]
78. [Evaluation of the degree of virulence of Sonne Shigella]. Vasil'eva IG; Khalitova EB; Lomanova GA; Sukhareva ME; Nesterina LF Lab Delo; 1972; 8():505-6. PubMed ID: 4124358 [No Abstract] [Full Text] [Related]
79. [Serodiagnosis and immunological aspects of Proteus infection. III. Immunological, bacteriological and pathomorphological parallels in experimental Proteus intestinal infections, mono- and mixed]. Bidnenko SI; Bernasovskaia EP; Barshteĭn IuA; Ganziĭ GP Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):105-10. PubMed ID: 6758428 [TBL] [Abstract][Full Text] [Related]
80. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]